Steven J. Kafka Joins Section 32 as Managing Partner
Summary
Section 32, a San Diego, CA-based venture capital firm investing at the frontiers of technology, healthcare and life sciences, appointed Steven J. Kafka, Ph.D., as a managing partner. Kafka will focus on supporting and expanding the firm’s investment portfolio and presence in Boston. Kafka currently serves as executive chairman at Thrive Earlier Detection Corp., and at ArcherDX, and will continue operating in those roles. Previously, Kafka was president and chief operating officer at Foundation Medicine Inc., where he helped lead the company’s growth including its initial public offering, collaboration with Roche, and rapid expansion of its operational activities. Led by Bill Maris, Founder, and Michael Pellini, M.D., Managing Partner, Section 32 invests primarily in US-based companies across biotechnology, therapeutics, advanced diagnostics, software, cybersecurity, machine learning, and artificial intelligence.